Sanofi reviews

The merger between Aventis & Sanofi was completed with the goal of being the biggest in mind. That has been accomplished to the detriment of every bit of culture that the values speak to. There is a facade that leadership wants to hear suggestions and ideas, but change does not occur because of it. There is no autonomy to do business based on your area's specific needs, and there is no fairness with evaluations - leadership buckets 100% by sales results (which are admittedly not always appropriate and not adjusted for regional performance curvew - how does an analytics team explain a national curve of 20% to ?) and changes methodology and goals on a quarterly basis, without explanation. The company is not looked at as a benchmark of excellence with physicians for products or salesmanship. There is a history of failed submissions and launches and not a bright future in the US in the near term.

The tax department is clearly not key decision taking in the organization. Hence it may be frustrating to work on a project without having a real impact on the decision process at the end.